EMA Medicine safety communications
Ontozry: adverse event;post-authorisation measure
Published by European Medicines Agency:
Summary
Adverse event;Post-authorisation measure
Medicine
Ontozry
- Category
- Medicine safety communications
- Product type
- Human medicine
- Active substance(s): cenobamate
- Therapeutic area: Epilepsy
- ATC code: N03AX
Measures and alternatives
- Regulatory outcome: Variation
Source: EMA — medicine safety communications — European Medicines Agency
Source: European Medicines Agency (EMA). Reproduced with acknowledgement of the source, in line with the EMA legal notice. EU Safety Radar is an independent information service; the text above presents the official data in the original language — the notice published by the authority is authoritative.
Open the original notice (www.ema.europa.eu) ↗